摘要
缺血性脑卒中作为常见的神经系统疾病,与动脉粥样硬化、高血压、糖尿病均有一定程度的相关性.目前新型脂肪因子正在深入研究中,其中网膜素-1(omentin-1)是一种由内脏脂肪组织产生的脂肪因子,参与了动脉粥样硬化等疾病的病理过程,有抗炎、抗动脉粥样硬化等作用.该文旨在阐明omentin-1对缺血性脑卒中的作用,可能在不同方面潜在地成为其生物标志物、药物、靶标.
Stroke,as a common neurological disease,is associated with atherosclerosis,hypertension and diabetes mellitus to some extent.At present,new adipokines are under in-depth study,among which omentin-1 is an adipokines produced by visceral adipose tissue,which has anti-inflammatory and anti-atherosclerosis effects.The purpose of this study was to elucidate the role of omentin-1 in ischemic stroke,which may be a potential biomarker,drug and target in different aspects.
作者
刘璐
毕鹏翔
董妍
郭艳芹
姚丽群
罗海龙
LIU Lu;BI Peng-xiang;DONG Yan;GUO Yan-qin;YAO Li-qun;LUO Hai-long(Mudanjiang Medical University,Mudanjiang,Heilongjiang,157000,China;Department of Neurology,Hongqi Hospital of Mudanjiang Medical University,Mudanjiang,Heilongjiang,157000,China)
出处
《中国血液流变学杂志》
CAS
2020年第3期401-405,共5页
Chinese Journal of Hemorheology
基金
黑龙江省卫生健康委科研课题(2019-406)